Your Lungs Work Differently. Here's the Genetic Reason.

Your beta-2 adrenergic receptor sits on the smooth muscle surrounding your airways. When you’re stressed, or exercising, or exposed to a trigger, your body releases adrenaline and noradrenaline. These hormones bind to ADRB2 receptors and tell your airway muscles to relax, allowing air to flow freely. It’s your lungs’ built-in escape hatch when pressure rises.

The Arg16Gly variant in ADRB2 is extremely common. Roughly 40% of the population carries at least one copy of the Gly allele. Here’s the problem: people with the Gly16 variant show significantly reduced responsiveness to beta-2 agonist inhalers, the standard emergency medications for airway narrowing. Your airways don’t relax as well in response to adrenaline, and medications that mimic adrenaline don’t work as effectively either. You might need higher doses, or you might find that your rescue inhaler doesn’t relieve your symptoms the way it does for other people.

You notice this most during exercise or when you’re stressed. Your breathing becomes labored faster than it should. Your chest tightens. A dose of your rescue inhaler might help a little, but not completely. Other people around you seem fine with the same trigger. You might be told your asthma is severe, when really your genetics mean you respond differently to standard treatment.

GSTM1 encodes a glutathione S-transferase enzyme that sits inside your cells and neutralizes oxidative stress, pollutants, and inflammatory byproducts. When you breathe in smoke, pollution, allergen proteins, or when your immune system fires up and creates free radicals, GSTM1 is responsible for clearing those toxic molecules before they damage your airways further.

Roughly 30-50% of the population has a complete deletion of GSTM1, meaning they carry zero copies of this gene. People without GSTM1 activity cannot efficiently clear oxidative stress and toxins from their airways. Inflammatory molecules accumulate. Your airways stay irritated longer. Allergen exposure or air pollution that another person’s body clears in hours might linger in your lungs for days, keeping your airway inflammation elevated.

You feel this as persistent throat irritation, lingering cough, or airways that stay reactive for days after exposure to something triggering. Smoke, perfume, pollution, or even vigorous exercise leave you struggling longer than seems reasonable. Your lungs feel vulnerable, as if they don’t have a good margin for error.

Interleukin-13 is an immune signaling molecule that your Th2 immune cells release in response to allergens. It tells your airway tissue to produce more mucus, to recruit eosinophils (a type of white blood cell), and to remodel your airway walls, making them thicker and more reactive. In small amounts, this is a normal immune response. But IL13 variants can push this response into overdrive.

Roughly 30-35% of the population carries genetic variants that amplify IL13 signaling. Higher IL13 activity drives airway eosinophilia, mucus hypersecretion, and airway remodeling, making asthma more severe and more persistent. If you have these variants, your airways don’t just tighten during an allergic reaction, they actually remodel. The airway walls get thicker. They produce more mucus baseline. Your lungs remain inflamed even when you’re not actively exposed to an allergen.

You experience this as a persistent productive cough, airways that feel chronically full, or asthma that doesn’t fully resolve even when you’re not around obvious triggers. Your lungs feel heavy. You might produce phlegm for hours after a single allergen exposure. Asthma controllers and antihistamines help, but you notice you’re always managing something.

Your vitamin D receptor (VDR) is a protein that sits inside immune cells and your airway tissue. When vitamin D binds to VDR, it tells your immune system to calm down, to produce fewer inflammatory cytokines, and to favor regulatory T cells over allergic immune responses. VDR is one of the body’s primary brakes on respiratory inflammation.

VDR has several common variants, most notably the FokI polymorphism. Roughly 50% of people carry variants that reduce VDR sensitivity to vitamin D. People with less efficient VDR variants require higher vitamin D levels to achieve the same immune-calming effect. Even if your vitamin D blood test is technically in range, your airways might still be responding as if you’re deficient because your immune cells aren’t receiving the signal strongly enough.

You notice this most seasonally or when you’re indoors more (less sun exposure). Your allergies feel worse. Your asthma or airway sensitivity seems more reactive. You might have been told to supplement vitamin D, and you do, but you don’t feel the improvement you expected. That’s because the dose that’s adequate for someone with better VDR function isn’t adequate for you.

Filaggrin is a structural protein that holds the cells of your skin and airway lining tightly together, creating a physical barrier that keeps allergens, bacteria, and irritants outside your cells. Without adequate filaggrin, your barrier is leaky. Allergen proteins slip through the gaps and reach your immune cells, priming them to mount an allergic response. Filaggrin defects are the gateway to the atopic march: eczema, then allergic rhinitis, then asthma.

FLG mutations like R501X and 2282del4 are carried by roughly 10% of people with European ancestry, and much higher rates in other populations. People with FLG mutations have demonstrably leaky barrier function; allergens penetrate deeper into airway tissue and create stronger immune sensitization. Your immune system sees allergens it shouldn’t have seen, and it remembers them. Over time, your list of triggers grows.

You might have had eczema as a child, or you still do. You’re allergic to many things, or your allergies developed recently. You notice that your throat and airways feel raw or irritated even without obvious allergen exposure. Your cough is often dry and irritating. Once you’re sensitized to something, you stay sensitized for a long time.

Tumor necrosis factor (TNF) is a master inflammatory cytokine. It activates mast cells, triggers immune cell recruitment, and amplifies inflammatory signaling throughout your body. In small amounts, TNF is protective and necessary. But TNF is tightly regulated by genetics. Some people’s bodies naturally produce more TNF; others produce less.

The TNF -308G>A variant is carried by roughly 30% of the population. People with the A allele produce higher baseline TNF-alpha, which drives mast cell activation and keeps your airways in a more reactive, inflamed state even when you’re not actively exposed to triggers. Your inflammatory baseline is higher. It takes less stimulus to push you over the threshold into symptoms.

You might notice that you react to things other people don’t: strong smells, sudden temperature changes, exercise in dry air, or emotional stress. Your airways feel primed. Even weather changes might trigger symptoms. You might have been told you have sensitive airways or reactive asthma, when really your TNF baseline is just set higher genetically.